Please assess the completion status of the following clinical trial:

Trial Title: Pilot Study of Pharmacology of Paracetamol Administered Per-oral Mucosa

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE1
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Healthy volunteers~* Aged over 18 years and not more than 50 years~* Males~* Values of vital signs before administration of the test products:~  * NOT between 100-140 mm Hg~ * PAD between 50-90 mm Hg~ * Radial pulse between 45-90 beats per minute~* Free from any treatment in the 7 days preceding inclusion including no use of analgesics or anti-inflammatories)~Exclusion Criteria:~* Contraindications to the administration of paracetamol~* Hypersensitivity to paracetamol~* History of hepatitis B or C~* Severe renal impairment~* Hepatic insufficiency~* Medical history and / or surgical judged by the investigator or his representative as being incompatible with the test, especially subjects with neuropathic pain~* Pathology evolutionary time of the review for inclusion~* Binge drinking, smoking (more than 10 cigarettes/day), coffee, tea or drinks containing caffeine (equivalent to more than 4 cups per day) or drug abuse~* Subject does not meet the selection criteria regarding their ability to discriminate the sensations resulting from noxious stimuli during psychometric testing~* Topic having all breaches of the oral mucosa (aphthae)

- Gender: MALE
- Minimum Age: 18 Years
- Maximum Age: 50 Years
- Healthy Volunteers: t

Based on this trial design, predict the completion outcome and termination type (if applicable).